Identify Emerging Risks and Evaluate the Effectiveness of Business, Compliance and Regulatory Controls
The life science industry’s most in-depth forum — driven by industry, for industry — to equip the internal audit and governance community with proven strategies for conducting thorough and detailed audits of high‑risk areas enterprise‑wide, including deep‑dive sessions on company culture audits, IT audits, FCPA/third‑party audits and cyber security audits.
Who Should Attend
You will benefit from attending this meeting if you work at a pharmaceutical, biotech or medical device company with involvement or responsibility for:
Internal Audit
Internal Controls
Compliance
Enterprise Risk Management
Corporate Governance
Finance
IT
Legal
Risk Management
This event also benefits consultants, software providers, auditing firms and IROs that provide enterprise risk & assurance services to the life sciences industries.
What to Expect
Standards and Frameworks for Excellence
- Discuss novel IA strategies for enhanced, risk-based auditing and reporting
- Stay ahead of the curve with an eye to emerging risks in a global, complex market
- Discover recent enforcement trends and top priorities of the SEC and DOJ
Best Practices for High-Risk Areas
- Third-Party risk, FCPA and ABAC
- Digital initiatives
- Data security, IT and cloud-based systems
- Managed markets
- Sales and marketing
- Clinical and R&D
- Patient assistance and support programs
- SOX, Rev Rec and GTN
- M&A and securities litigation
And More...
Customizable Programming and Valuable Networking
- 2 in-depth Workshops
- 2 tailored Tracks based on company size and scope
- 6 focused Breakouts covering top risk areas and next- gen audit tactics
- 8+ hours of networking with the IA and controller community